DC
AXDX

Deere & Company’s Accelerate Diagnostics AXDX Stock Holding History

Deere & Company’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-894
Closed -$232K – 968
2014
Q2 		$232K Buy
+894
New +$195K 0.01% 800

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Wood Investment Counsel Denver, Colorado $669M AUM 20.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MGM
Miura Global Management New York $43.8M AUM 53.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Selkirk Management Chatham, New Jersey $294M AUM 26.84% 1-Year Est. Return

Deere & Company's AXDX Position: Q3 2014 in Review

Deere & Company sold out of Accelerate Diagnostics (AXDX) in Q3 2014, closing a stake of 894 shares — an estimated $232K sold.

Deere & Company first reported a position in AXDX in Q2 2014 and held it in 1 quarter. The position peaked at $232K in Q2 2014. 71 funds tracked by Wall St. Rank hold AXDX as of Q3 2014.

  • Deere & Company reported no remaining Accelerate Diagnostics position as of Q3 2014 after selling out during the quarter.
  • Deere & Company sold 894 Accelerate Diagnostics shares in Q3 2014, an estimated $232K.
  • Deere & Company first reported a position in Accelerate Diagnostics in Q2 2014 and held it in 1 quarter.
  • Deere & Company's Accelerate Diagnostics position peaked at $232K in Q2 2014.
  • 71 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2014.

Based on Deere & Company's 13F filing for Q3 2014, filed 12 Nov 2014.